Cargando…
Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
Alterations in the NRF2/KEAP1 pathway result in the constitutive activation of NRF2, leading to the aberrant induction of antioxidant and detoxification enzymes, including NQO1. The NQO1 bioactivatable agent β-lapachone can target cells with high NQO1 expression but relies in the generation of react...
Autores principales: | Torrente, Laura, Prieto-Farigua, Nicolas, Falzone, Aimee, Elkins, Cody M., Boothman, David A., Haura, Eric B., DeNicola, Gina M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997906/ https://www.ncbi.nlm.nih.gov/pubmed/32007910 http://dx.doi.org/10.1016/j.redox.2020.101440 |
Ejemplares similares
-
Distinct Nrf2 Signaling Thresholds Mediate Lung Tumor Initiation and Progression
por: DeBlasi, Janine M., et al.
Publicado: (2023) -
Correction: Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
por: Kang, Yun Pyo, et al.
Publicado: (2019) -
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
por: Kang, Yun Pyo, et al.
Publicado: (2019) -
Comprehensive Metabolic Tracing Reveals the Origin and Catabolism of Cysteine in Mammalian Tissues and Tumors
por: Yoon, Sang Jun, et al.
Publicado: (2023) -
A CRISPR screen identifies redox vulnerabilities for KEAP1/NRF2 mutant non-small cell lung cancer
por: Jiang, Chang, et al.
Publicado: (2022)